Involvement of inflammatory cytokines in central nervous system injury.
about
Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal dietDistinct behavioral consequences of short-term and prolonged GABAergic depletion in prefrontal cortex and dorsal hippocampus.Adenosine A(2A) receptor mediates microglial process retractionEndothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.TNF-alpha dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activationBrain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsArsenic affects inflammatory cytokine expression in Gallus gallus brain tissues.Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury.Implications of gliotransmission for the pharmacotherapy of CNS disorders.The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations.CCL2 modulates cytokine production in cultured mouse astrocytes.Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation.Effect of hypoxia on expression of selected proteins involved in regulation of apoptotic activity in striatum of newborn piglets.Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitisTumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementiaStrain-dependent variation in the early transcriptional response to CNS injury using a cortical explant system.Vascular Protection Following Cerebral Ischemia and Reperfusion.IL-4 Knock Out Mice Display Anxiety-Like BehaviorSecretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disordersInvestigational anti-inflammatory agents for the treatment of ischaemic brain injury.Acute rosiglitazone treatment during reperfusion after hyperglycemic stroke is neuroprotective not vascular protectiveAbsence of caspase 8 and high expression of PED protect primitive neural cells from cell death.Microglia in cerebral ischemia: molecular actions and interactions.Profile of Cytokines and Chemokines Triggered by Wild-Type Strains of Rabies Virus in MiceRegulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathwayPeripheral T-lymphocyte and natural killer cell population imbalance is associated with septic encephalopathy in patients with severe sepsis.Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion.Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.Integration of cytokine biology and lipid metabolism in strokePost-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury.Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.Role of Lipids in Brain Injury and Diseases.A chronically implantable, hybrid cannula-electrode device for assessing the effects of molecules on electrophysiological signals in freely behaving animals.CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.Glial-mediated inflammation underlying parkinsonism.Stress-induced neuroinflammation: mechanisms and new pharmacological targets.Hyperthermia exacerbates ischaemic brain injury.Effects of ulinastatin on global ischemia via brain pro-inflammation signal.
P2860
Q28572572-ABC53D10-97CC-4E00-92F6-9944B5638BB3Q30420236-01C0FF67-AFEF-404E-BBD2-4C37C86724C3Q30488894-887430CD-087E-445D-87DB-E753657395FDQ30734754-D2C05440-54D4-4432-BC96-CB84F64DD207Q33226492-D5500DDA-89BC-48C2-9111-D32D22389222Q33614467-1DFAD706-FAAF-46DE-8A40-7E61B74427B5Q33767711-4541C1D3-5332-4A67-BCC6-23A9F1430599Q33939361-6A80463F-6503-4F55-B62B-764F0C248B08Q33971765-40109403-8D15-40AF-BC30-5E9691076092Q34039325-1C7B35FD-2861-419F-B1E5-3E63B2EB057EQ34243826-079192A1-6C09-403B-9769-984CBB681615Q34306394-51BF9095-AE68-4249-A6E5-3FF0D080BBA2Q34765663-BF5D0950-69F8-4AD4-936A-198EFBF56BBDQ35193621-D8708707-C7C9-4BE5-89D5-884FC7EFA515Q35197030-F12A63B4-BBE2-4608-B12D-8CD6CCD2407EQ35338504-04728E46-1FCE-4722-BB4C-50CA2B563593Q35551681-55956BB8-AFB0-4C05-9FC5-13C9E7FCEBBBQ35696219-1E1A715F-7A3F-47F5-837C-911A17D25F79Q35757950-1663990B-CB90-4069-ADF5-5DB8258979CBQ35803795-B67F2021-FE87-4017-978E-E8E480DA260FQ35915801-10229FC6-E47B-4DCC-ABD7-2BC44F10AED3Q36120766-E801782B-25FA-493C-9151-46ACB79DBD5FQ36359324-625D326F-9A48-479E-90C6-41CBB246ECFAQ36399537-18D753F0-670E-40B9-A246-C102BC75033DQ36538353-525AA095-1F0F-444F-ABC1-FC39CA971489Q36575430-1FC10016-E118-448F-9B95-EFB8712717D1Q36614373-8CD277D0-C94A-47A4-ADF8-11ABA4E5000EQ36640252-4A287325-1AA0-4BC3-BE13-FE0B2469770DQ36756418-5604C57F-69FE-4AF3-A91E-5875AA4CE0B0Q36925788-119BBFE5-CE70-4F56-9A4F-7384EC1A484DQ36992077-2D76E447-4626-49A4-BDF0-363EC1AB5A15Q37023836-06160F19-0D1D-4B99-825D-35F5379D516AQ37045248-B7EED884-FA57-44D6-BE1E-0CDD5038DD8CQ37051065-6E2139F5-CEDD-45F3-A111-A2AF78C02DA9Q37195215-753402BD-FE8E-45C1-B213-57BD4F5FE59DQ37227396-A27B9A8C-60EE-4207-8F6A-51ED44D7D35FQ37287778-96E5073A-8949-4CEC-A526-C2DBEDBCB043Q37369927-585F588D-1311-4086-9A30-7A2F095185AFQ37582010-5E4F0779-C623-4320-8F0F-DEF8805F9784Q37585458-2C64FB30-E06A-4B06-AFDF-7EFB959F5329
P2860
Involvement of inflammatory cytokines in central nervous system injury.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Involvement of inflammatory cytokines in central nervous system injury.
@ast
Involvement of inflammatory cytokines in central nervous system injury.
@en
Involvement of inflammatory cytokines in central nervous system injury.
@nl
type
label
Involvement of inflammatory cytokines in central nervous system injury.
@ast
Involvement of inflammatory cytokines in central nervous system injury.
@en
Involvement of inflammatory cytokines in central nervous system injury.
@nl
prefLabel
Involvement of inflammatory cytokines in central nervous system injury.
@ast
Involvement of inflammatory cytokines in central nervous system injury.
@en
Involvement of inflammatory cytokines in central nervous system injury.
@nl
P1476
Involvement of inflammatory cytokines in central nervous system injury.
@en
P2093
Ashfaq Shuaib
Chen Xu Wang
P304
P356
10.1016/S0301-0082(02)00010-2
P577
2002-06-01T00:00:00Z